The Mount Sinai Hospital is a 1,171-bed, tertiary- and quaternary-care teaching facility located on the Upper East Side of Manhattan. It is the flagship hospital of the Mount Sinai Health System, which includes: Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West, Mount Sinai Queens, Mount Sinai Brooklyn and New York Eye and Ear Infirmary of Mount Sinai, multiple free-standing ambulatory surgery centers and an extensive network of ambulatory care locations throughout New York. The Mount Sinai Hospital spans a five block area between Fifth and Madison Avenues, directly across from New York's beautiful Central Park. The Mount Sinai Hospital services a diverse patient population that spans the spectrum from neonates to geriatrics. The recently opened Leon and Norma Hess Center for Science and Medicine is a state-of-the-art research facility that provides extensive outpatient oncology and other infusion services.
The Pharmacy Department at The Mount Sinai Hospital follows a decentralized model. We have a number of pharmacy satellites located on patient units and have centralized many distributive functions. Our Clinical Services include a Drug Information Center, Investigational Drug Service, Oncology, Transplant, Pediatrics, Critical Care and a pharmacist-managed ID approval system. We maintain a formal teaching affiliation with Long Island University, St. John's University, and Touro University and informal affiliations with a number of other schools of pharmacy.
The pharmacy department offers FOUR (4) PGY1 residency positions, as well as FOUR (4) PGY2 residencies. Our PGY2 residencies are offered in Oncology, Solid Organ Transplant, Infectious Disease, and Critical Care. Our Infectious Disease and Critical Care residency programs are co-sponsored by Touro College of Pharmacy.
Our 4 PGY1 residents have opportunities to practice in a dynamic, fast-paced, teaching environment, serving a diverse patient population. Residents participate in medication safety, EMR development, prospective patient monitoring, transitions of care services, drug policy, interdisciplinary committees, regulatory readiness, and rapid response teams. They also have supervisory responsibilities, and complete a major project. Ample opportunity to present journal clubs, case conferences and mentor students is provided.
All residents complete internal medicine, infectious disease, administration, and a research block. Drug info is a required longitudinal rotation.
Residents select at least one general practice, one specialty practice and one advanced practice
General practice options: emergency medicine, pediatrics, nutrition support
Specialty options: oncology or transplant
Advanced practice options: critical care or a second rotation in another area
Elective rotations include cardiology, geriatrics, clinical trials, med safety, nephrology, pharmacogenomics, palliative care, others can be arranged based upon availability and resident interest
Registration and submission of application through PhORCAS.
Letter of interest.
Professional writing sample.
THREE letters of recommendation, at least one academic and one professional.
ALL post-secondary transcripts, including pre-pharmacy coursework and prior degrees.
Applicants must be eligible for a NYS Pharmacy license and obtain an intern permit prior to starting the residency.
All residents must become licensed in NYS no later than November 1st.
About Mount Sinai Hospital PGY1 Pharmacy Residency
Mount Sinai Health System includes: Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West, Mount Sinai Queens, Mount Sinai Brooklyn and New York Eye and Ear Infirmary of Mount Sinai, 12 free-standing ambulatory surgery centers and an extensive network of ambulatory care locations throughout New York. The Mount Sinai Hospital is a 1,171-bed, tertiary- and quaternary-care teaching facility located on the Upper East Side of Manhattan. The Mount Sinai Hospital services a diverse patient population that spans the spectrum from neonates to geriatrics. There is a long history of clinical excellence and scientific discovery which continues today at Mount Sinai. Dr. Bernard Sachs, discoverer of Tay-Sachs Disease, Dr. Burill Crohn, researcher of Crohn’s Disease, Dr. Bela Schick, developer of the Schick test and Dr. Barry Coller, developer of abciximab, all practiced at Mount Sinai. The hospital is a clinical teaching site for students from a variety of health-professions, including pharmacy, nursing, medicine, rehabilitation therapists, and clinical nutrition.